ABCG2 and triple-negative breast carcinoma: Considering this literature and cognitive gap, as well as the greater sensitivity of MDA-MB-231 triple-negative breast cancer cells to selenoesters [25,26], we evaluated the effects of this group of compounds on ABC transporters, i.e., BCRP, MDR1, and MRP1.